Phase II study of concurrent carboplatin, pemetrexed, and radiotherapy for limited stage of small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2013
At a glance
- Drugs Carboplatin (Primary) ; Pemetrexed (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 17 Dec 2009 Actual end date (October 2008) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual patient number (4) added as reported by ClinicalTrials.gov.
- 28 Jan 2008 Status change from recruiting to discontinued as reported by clinicaltrials.gov.